Nuevolution AB (publ) announces timing for the fourth quarter release and webcast
Stockholm, 29 August 2016 – Nuevolution AB (publ) (NUE.ST) announces today that it will report its fourth quarter 2015/16 financial results on Tuesday 6 September at 8:00 CEST.
On Tuesday 6 September at 13:00 CEST, the company’s executive management will host a conference call and webcast discussion of the results and provide an update on the pipeline programs and partnering activities. Access to the event can be obtained as follows:
LIVE access on Tuesday 6 September at 13:00 CEST
SE: +46 85 664 2669
DK: +45 8233 3178
UK: +44 20 3008 9808
US: +1 855 7532 235
For more information, please contact:
Alex Haahr Gouliaev, CEO
Phone: +45 3913 0902
Henrik Damkjær Simonsen, CFO
Phone: +45 3913 0947
Information about Nuevolution AB (publ)
Nuevolution AB (publ) is a leading small molecule drug discovery biotech company founded in 2001, and headquartered in Copenhagen, Denmark. Nuevolution partners its discovery platform and programs with pharmaceutical and biotechnology companies to seek future benefit of patients in need of novel medical treatment option. Nuevolution’s internal programs are focused on therapeutically important targets within inflammation, oncology and immuno-oncology.
Nuevolution AB (publ) is required to disclose the information provided herein pursuant to the Securities Markets Act. The information was sent for publication on Monday 29 August, 13.00 (CEST).
Nuevolution AB (publ) is listed at Nasdaq First North in Stockholm, Sweden (ticker: NUE.ST). Västra Hamnen Corporate Finance AB acts as Certified Advisor to Nuevolution AB (publ). More information about Nuevolution can be found on: www.nuevolution.com